
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PIP (Prolactin Induced Protein):** Often associated with breast tissue and is known to be involved in immune response and cell signaling.<br>- **MUCL1 (Mucin Like 1):** Expressed in breast tissue and associated with breast cancer.<br>- **CRIP1 (Cysteine Rich Protein 1):** Involved in zinc ion binding and may play a role in cellular growth and differentiation.<br>- **AZGP1 (Alpha-2-Glycoprotein 1, Zinc-Binding):** Known to be involved in lipid metabolism and is often expressed in breast tissue.<br>- **IGFBP5 (Insulin Like Growth Factor Binding Protein 5):** Plays a role in cell growth, apoptosis, and is often expressed in breast tissue.<br>- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Also known as Mammaglobin, highly specific to breast tissue and often used as a marker for breast cancer.<br>- **KRT18 (Keratin 18):** A type I cytokeratin, often expressed in epithelial cells, including those in the breast.<br><br>### Step 2: List the Key Cell Type Markers<br>- **SCGB2A2 (Mammaglobin):** Highly specific to mammary epithelial cells and often used as a marker for breast cancer.<br>- **PIP:** Commonly expressed in mammary gland tissue.<br>- **MUCL1:** Associated with breast epithelial cells.<br>- **KRT18:** Expressed in simple epithelial cells, including those in the breast.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **SCGB2A2, PIP, MUCL1, KRT18** are strongly associated with mammary epithelial cells.<br>- **AZGP1** is also expressed in breast tissue and is linked to lipid metabolism.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **mammary epithelial cells**. This is supported by the presence of SCGB2A2, PIP, MUCL1, and KRT18, which are all markers associated with breast epithelial cells.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells:** These cells are characterized by the expression of SCGB2A2, PIP, and KRT18, which are markers for luminal cells in the mammary gland.<br>2. **Basal/Myoepithelial Cells:** While less likely given the marker list, KRT18 can sometimes be expressed in basal cells, but the lack of specific basal markers makes this less probable.<br>3. **Ductal Epithelial Cells:** These cells can also express some of the markers listed, but the high expression of SCGB2A2 and PIP leans more towards luminal cells.<br><br>**Most Likely Subtype:** The most likely subtype is **Luminal Epithelial Cells** due to the strong expression of SCGB2A2, PIP, and KRT18, which are characteristic of luminal cells in the breast.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of mammary epithelial cells, specifically luminal epithelial cells. This conclusion is based on the high expression of markers such as SCGB2A2, PIP, and KRT18, which are well-documented in the literature and databases as being associated with luminal cells in the mammary gland.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers listed in the annotation (PIP, MUCL1, CRIP1, AZGP1, IGFBP5, SCGB2A2, KRT18) are all present in the provided marker list.<br>   - The key cell type markers (SCGB2A2, PIP, MUCL1, KRT18) are also present in the marker list and are consistent with the identification of mammary epithelial cells, specifically luminal epithelial cells.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation does not suggest the presence of multiple distinct cell types strongly supported by several high-ranking markers. The markers predominantly point towards mammary epithelial cells, particularly luminal epithelial cells.<br>   - The analysis correctly identifies luminal epithelial cells as the most likely subtype based on the strong expression of SCGB2A2, PIP, and KRT18.<br><br>Overall, the annotation is well-supported by the marker list and aligns with known databases and literature, confirming the identification of the cell cluster as mammary epithelial cells, specifically luminal epithelial cells.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Mammary Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal/Myoepithelial Cells</li><li>Ductal Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its implications for identifying cell types within the context of human breast cancer. The analysis correctly identifies key markers such as SCGB2A2, PIP, MUCL1, and KRT18, which are well-documented in the literature as being associated with mammary epithelial cells, particularly luminal epithelial cells. This is a significant strength, as these markers are indeed highly specific to the cell type in question.<br><br>The annotation process is thorough, following a structured approach that includes listing key functional and cell type markers, cross-referencing with known databases, and determining the most probable general and sub-cell types. This methodical approach ensures that the annotation is not only based on the presence of individual markers but also considers their collective expression patterns, which is crucial for accurate cell type identification.<br><br>One of the strengths of the annotation is its balanced consideration of multiple markers. The analysis does not overly focus on a single marker but instead evaluates a range of markers to support the identification of luminal epithelial cells. This comprehensive approach helps capture the general picture of the cell populations present in the dataset.<br><br>However, there are a few areas where the annotation could be improved. While the analysis correctly identifies luminal epithelial cells as the most likely subtype, it could have provided more detailed reasoning for the exclusion of other potential cell types, such as basal/myoepithelial cells or ductal epithelial cells. Although these are mentioned, the justification for their lower likelihood is not as robust as it could be.<br><br>Additionally, the annotation could have considered the rank of the markers more explicitly. While the presence of key markers is acknowledged, the analysis does not emphasize the importance of their rank in the list, which could provide further insight into their relative significance.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present, with a strong focus on the most likely subtype. There are no obvious misclassifications, and the analysis aligns well with known databases and literature.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    